VistaGen Therapeutics, Inc.
VTGN
$2.22
-$0.12-5.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.09M | -12.96M | -10.73M | -9.52M | -6.35M |
| Total Depreciation and Amortization | 161.00K | 157.00K | 151.00K | 146.50K | 143.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 978.00K | 972.00K | 1.14M | 528.50K | 507.00K |
| Change in Net Operating Assets | 2.67M | 946.00K | -1.43M | 1.65M | 953.00K |
| Cash from Operations | -10.28M | -10.89M | -10.87M | -7.20M | -4.75M |
| Capital Expenditure | 0.00 | -61.00K | -42.00K | -28.70K | -32.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -422.00K | -7.73M | -5.43M | -- | -- |
| Cash from Investing | -422.00K | -7.79M | -5.47M | -28.70K | -32.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 1.00K | 1.00K |
| Issuance of Common Stock | 1.17M | 0.00 | 88.00K | -- | 129.76M |
| Repurchase of Common Stock | -- | -- | -- | -168.80K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -36.03M |
| Cash from Financing | 1.17M | 0.00 | 88.00K | -167.80K | 93.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.53M | -18.67M | -16.25M | -7.39M | 88.95M |